2,2-Dimethyloxolan-3-one, 98%, 1g

(5R)-5-(AMINOMETHYL)-1,3-OXAZOLIDIN-2-ONE HCL, 95.0%, 250mg

3-(2-(((4-Carbamoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid (Dabigatran Impurity), 97%, 50mg

Ethyl 3-amino-4,4,4-trifluorocrotonate, 96.0%, 25g

p-Xileno, mínimo 99 %, para síntesis, 2,5 l, envase de vidrio

(E)-Pent-3-en-2-one, 98%, 100mg

2-(4-Cyano-3-fluorophenyl)acetic acid, 95.0%, 5g

1H-Indole-1-carboxylic acid, 4-(acetyloxy)octahydro-, 1,1-dimethylethyl ester, (3aS,4R,7aS)-, 97%, 100mg

3,3'-(Ethylenedithio)dipropionitrile>97.0%(GC)1g

3-Hydroxy-7-methoxy-2-naphthoic acid, 95.0%, 5g

2,5-Dimethyl-4-nitrobenzo[d]thiazole, 95.0%, 250mg

(2E)-3-(2,4-difluorophenyl)prop-2-enoyl chloride, 25g

5-(Trimethylsilyl)-1,2,3,4,5-pentamethyl-1,3-cyclopentadiene>95.0%(GC)1mL